South Korea had administered more COVID-19 vaccine doses per 100 people than other developed countries by the end of March 2022. A new article published in OMICS: A Journal of Integrative Biology presents six pivotal lessons ...
Sep 22, 2022
0
6
A needle-free vaccine patch could better fight COVID-19 variants, such as Omicron and Delta, than a traditional needle vaccine according to a University of Queensland study in mice.
Jul 28, 2022
0
62
When COVID-19 created an urgent need for vaccines that could be made quickly, safely and cost-effectively, traditional manufacturing approaches were not sufficient to meet the demand. Biopharmaceutical companies therefore ...
Jun 13, 2022
0
5
A COVID-19 vaccine effective against multiple variants is possible before the end of 2022, the head of US pharmaceutical giant Pfizer said Wednesday.
Apr 13, 2022
0
41
A new study from Lund University in Sweden on how the Pfizer-BioNTech COVID-19 vaccine affects human liver cells under experimental conditions, has been viewed more than 800,000 times in just over a week. The results have ...
Mar 10, 2022
0
159
French pharmaceuticals giant Sanofi said Wednesday that its COVID-19 vaccine, developed with Britain's GSK, had delivered positive results after nearly a year of delays left it lagging far behind its rivals.
Feb 23, 2022
0
3
As black-legged ticks crawl their way across Michigan, scientists hope a new vaccine in development could make their presence less menacing.
Jan 3, 2022
0
108
An investigational COVID-19 vaccine made by Novavax was found to be 90 percent effective at preventing COVID-19 illness, according to results from a Phase 3 clinical trial published today in the New England Journal of Medicine. ...
Dec 16, 2021
0
75
West African nations need to drastically ramp up their COVID-19 vaccination programmes by factor of 10 if they are to reach at least 60% coverage by 2022 and achieve the population level immunity needed to bring the pandemic ...
Dec 14, 2021
0
2
Wealthier nations should pay a COVID-19 vaccine tax as part of the price they pay to manufacturers, to ensure a fairer distribution of the jab to poorer nations, argues a political scientist in the Journal of Medical Ethics.
Nov 15, 2021
0
1
